Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr;179(8):1769-1783.
doi: 10.1111/bph.15750. Epub 2022 Feb 3.

A positive allosteric modulator for the muscarinic receptor (M1 mAChR) improves pathology and cognitive deficits in female APPswe/PSEN1ΔE9 mice

Khaled S Abd-Elrahman  1   2   3 , Shaarika Sarasija  1   2 , Tash-Lynn L Colson  1   2 , Stephen S G Ferguson  1   2
Affiliations
Free article

A positive allosteric modulator for the muscarinic receptor (M1 mAChR) improves pathology and cognitive deficits in female APPswe/PSEN1ΔE9 mice

Khaled S Abd-Elrahman et al. Br J Pharmacol. 2022 Apr.
Free article

Abstract

Background and purpose: Alzheimer's disease (AD) is a neurodegenerative disease characterized by progressive cognitive decline, and women account for 60% of diagnosed cases. β-Amyloid (Aβ) oligomers are considered the principal neurotoxic species in AD brains. The M1 muscarinic ACh receptor (M1 mAChR) plays a key role in memory and learning. M1 mAChR agonists show pro-cognitive activity but cause many adverse off-target effects. A new orally bioavailable M1 mAChR positive allosteric modulator (PAM), VU0486846, is devoid of direct agonist activity or adverse effects but was not tested for disease-modifying efficacy in female AD mice.

Experimental approach: Nine-month-old female APPswe/PSEN1ΔE9 (APPswe) and wildtype mice were treated with VU0486846 in drinking water (10 mg·kg-1 ·day-1 ) for 4 or 8 weeks. Cognitive function of mice was assessed after treatment, and brains were harvested for biochemical and immunohistochemical assessment.

Key results: VU0486846 improved cognitive function of APPswe mice when tested in novel object recognition and Morris water maze. This was paralleled by a significant reduction in Aβ oligomers and plaques and neuronal loss in the hippocampus. VU0486846 reduced Aβ oligomer production in APPswe mice by increasing M1 mAChR expression and shifting the processing of amyloid precursor protein from amyloidogenic cleavage to non-amyloidogenic cleavage. Specifically, VU0486846 reduced the expression of β-secretase 1 (BACE1), whereas it enhanced the expression of the α-secretase ADAM10 in APPswe hippocampus.

Conclusion and implications: Using M1 mAChR PAMs can be a viable disease-modifying approach that should be exploited clinically to slow AD in women.

Keywords: GPCR; memory; muscarinic; secretase; sex differences; β-amyloid.

PubMed Disclaimer

References

REFERENCES

    1. Abd-Elrahman, K. S., Albaker, A., de Souza, J. M., Ribeiro, F. M., Schlossmacher, M. G., Tiberi, M., Hamilton, A., & Ferguson, S. S. G. (2020). Aβ oligomers induce pathophysiological mGluR5 signaling in Alzheimer's disease model mice in a sex-selective manner. Science Signaling, 13(662), eabd2494. https://doi.org/10.1126/scisignal.abd2494
    1. Abd-Elrahman, K. S., & Ferguson, S. S. G. (2021). Noncanonical metabotropic glutamate receptor 5 signaling in Alzheimer's disease. Annual Review of Pharmacology and Toxicology, 62(1), 235-254. https://doi.org/10.1146/ANNUREV-PHARMTOX-021821-091747
    1. Abd-Elrahman, K. S., Hamilton, A., Albaker, A., & Ferguson, S. S. G. (2020). mGluR5 contribution to neuropathology in Alzheimer mice is disease stage-dependent. ACS Pharmacology & Translational Science, 3(2), 334-344. https://doi.org/10.1021/acsptsci.0c00013
    1. Abd-Elrahman, K. S., Hamilton, A., Hutchinson, S. R., Liu, F., Russell, R. C., & Ferguson, S. S. G. (2017). mGluR5 antagonism increases autophagy and prevents disease progression in the zQ175 mouse model of Huntington's disease. Science Signaling, 10(510), eaan6387. https://doi.org/10.1126/scisignal.aan6387
    1. Abd-Elrahman, K. S., Hamilton, A., Vasefi, M., & Ferguson, S. S. G. (2018). Autophagy is increased following either pharmacological or genetic silencing of mGluR5 signaling in Alzheimer's disease mouse models. Molecular Brain, 11(1), 19. https://doi.org/10.1186/s13041-018-0364-9

Publication types

Substances

LinkOut - more resources